NovelStem International Corp. (NSTM)
USD 0.01
(23.46%)
USD 0.01
(23.46%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.52 Million USD | -57.49% |
| 2022 | -422.43 Thousand USD | 14.75% |
| 2021 | -495.53 Thousand USD | -115.17% |
| 2020 | -230.29 Thousand USD | 0.0% |
| 2013 | -4.88 Million USD | 14.29% |
| 2012 | -5.7 Million USD | 5.8% |
| 2011 | -6.05 Million USD | 21.02% |
| 2010 | -7.66 Million USD | -139.68% |
| 2009 | -3.19 Million USD | 73.61% |
| 2008 | -12.11 Million USD | -20.99% |
| 2007 | -10.01 Million USD | -58.77% |
| 2006 | -6.3 Million USD | 29.02% |
| 2005 | -8.88 Million USD | 10.72% |
| 2004 | -9.95 Million USD | -31.7% |
| 2003 | -7.55 Million USD | 90.54% |
| 2002 | -79.91 Million USD | -86.92% |
| 2001 | -42.75 Million USD | 18.9% |
| 2000 | -52.71 Million USD | -158.41% |
| 1999 | -20.4 Million USD | -155.0% |
| 1998 | -8 Million USD | -25.0% |
| 1997 | -6.4 Million USD | 11.11% |
| 1996 | -7.2 Million USD | 13.25% |
| 1995 | -8.3 Million USD | -36.07% |
| 1994 | -6.1 Million USD | -662.5% |
| 1993 | -800 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -144.03 Thousand USD | 23.06% |
| 2024 Q1 | -183.31 Thousand USD | -512.67% |
| 2023 Q1 | -164.79 Thousand USD | -4.5% |
| 2023 FY | -665.28 Thousand USD | -57.49% |
| 2023 Q2 | -2.71 Million USD | -1549.97% |
| 2023 Q4 | -29.92 Thousand USD | 94.54% |
| 2023 Q3 | -548.42 Thousand USD | 79.83% |
| 2022 Q3 | -206.21 Thousand USD | 10.18% |
| 2022 FY | -422.43 Thousand USD | 14.75% |
| 2022 Q1 | 171.04 Thousand USD | 231.98% |
| 2022 Q2 | -229.57 Thousand USD | -234.22% |
| 2022 Q4 | -157.69 Thousand USD | 23.53% |
| 2021 Q4 | -129.59 Thousand USD | 2.69% |
| 2021 Q3 | -133.17 Thousand USD | -25.9% |
| 2021 Q2 | -105.78 Thousand USD | 16.69% |
| 2021 FY | -495.53 Thousand USD | -115.17% |
| 2021 Q1 | -126.97 Thousand USD | 0.0% |
| 2020 FY | -230.29 Thousand USD | 0.0% |
| 2013 Q2 | -1.19 Million USD | 12.61% |
| 2013 Q3 | -1.26 Million USD | -5.94% |
| 2013 Q4 | -1.05 Million USD | 17.03% |
| 2013 Q1 | -1.36 Million USD | 85.17% |
| 2013 FY | -4.88 Million USD | 14.29% |
| 2012 FY | -5.7 Million USD | 5.8% |
| 2012 Q3 | 1.05 Million USD | 166.7% |
| 2012 Q1 | -975.62 Thousand USD | -9.16% |
| 2012 Q4 | -9.23 Million USD | -972.7% |
| 2012 Q2 | -1.58 Million USD | -62.67% |
| 2011 FY | -6.05 Million USD | 21.02% |
| 2011 Q3 | -1.77 Million USD | -33.61% |
| 2011 Q2 | -1.33 Million USD | 34.97% |
| 2011 Q1 | -2.04 Million USD | 63.05% |
| 2011 Q4 | -893.73 Thousand USD | 49.77% |
| 2010 Q2 | -188.22 Thousand USD | 84.51% |
| 2010 Q3 | -717.74 Thousand USD | -281.32% |
| 2010 Q4 | -5.54 Million USD | -672.28% |
| 2010 FY | -7.66 Million USD | -139.68% |
| 2010 Q1 | -1.21 Million USD | -62.68% |
| 2009 Q3 | -675.52 Thousand USD | -359.12% |
| 2009 Q2 | 260.7 Thousand USD | 112.8% |
| 2009 FY | -3.19 Million USD | 73.61% |
| 2009 Q1 | -2.03 Million USD | 67.45% |
| 2009 Q4 | -746.89 Thousand USD | -10.56% |
| 2008 FY | -12.11 Million USD | -20.99% |
| 2008 Q4 | -6.25 Million USD | -215.99% |
| 2008 Q3 | -1.97 Million USD | 5.18% |
| 2008 Q2 | -2.08 Million USD | 36.99% |
| 2008 Q1 | -3.31 Million USD | -40.7% |
| 2007 Q2 | -1.31 Million USD | 54.26% |
| 2007 Q1 | -2.86 Million USD | -164.65% |
| 2007 Q4 | -2.35 Million USD | 1.37% |
| 2007 FY | -10.01 Million USD | -58.77% |
| 2007 Q3 | -2.38 Million USD | -81.95% |
| 2006 Q3 | -1.85 Million USD | -75.86% |
| 2006 FY | -6.3 Million USD | 29.02% |
| 2006 Q4 | -1.08 Million USD | 41.46% |
| 2006 Q2 | -1.05 Million USD | 42.86% |
| 2006 Q1 | -1.84 Million USD | -71.04% |
| 2005 Q3 | -2.47 Million USD | -3.64% |
| 2005 FY | -8.88 Million USD | 10.72% |
| 2005 Q4 | -1.07 Million USD | 56.44% |
| 2005 Q2 | -2.38 Million USD | 19.04% |
| 2005 Q1 | -2.94 Million USD | 21.77% |
| 2004 Q1 | -1.86 Million USD | -44.46% |
| 2004 Q2 | -1.32 Million USD | 29.07% |
| 2004 Q4 | -3.76 Million USD | -25.66% |
| 2004 Q3 | -2.99 Million USD | -126.9% |
| 2004 FY | -9.95 Million USD | -31.7% |
| 2003 Q2 | -2.21 Million USD | 3.22% |
| 2003 Q3 | -1.77 Million USD | 19.85% |
| 2003 Q4 | -1.28 Million USD | 27.2% |
| 2003 FY | -7.55 Million USD | 90.54% |
| 2003 Q1 | -2.28 Million USD | 38.92% |
| 2002 Q1 | -7.39 Million USD | 58.66% |
| 2002 Q2 | -6.51 Million USD | 11.93% |
| 2002 Q4 | -3.73 Million USD | 94.0% |
| 2002 Q3 | -62.3 Million USD | -857.01% |
| 2002 FY | -79.91 Million USD | -86.92% |
| 2001 Q4 | -17.88 Million USD | -115.74% |
| 2001 FY | -42.75 Million USD | 18.9% |
| 2001 Q2 | -8.02 Million USD | 4.13% |
| 2001 Q1 | -8.36 Million USD | 55.91% |
| 2001 Q3 | -8.28 Million USD | -3.31% |
| 2000 Q4 | -18.97 Million USD | -60.79% |
| 2000 Q2 | -11.77 Million USD | -15.84% |
| 2000 FY | -52.71 Million USD | -158.41% |
| 2000 Q1 | -10.16 Million USD | 8.46% |
| 2000 Q3 | -11.8 Million USD | -0.29% |
| 1999 Q1 | -1.6 Million USD | 48.39% |
| 1999 Q4 | -11.1 Million USD | -136.17% |
| 1999 Q3 | -4.7 Million USD | -56.67% |
| 1999 Q2 | -3 Million USD | -87.5% |
| 1999 FY | -20.4 Million USD | -155.0% |
| 1998 FY | -8 Million USD | -25.0% |
| 1998 Q3 | -1.5 Million USD | 21.05% |
| 1998 Q2 | -1.9 Million USD | -35.71% |
| 1998 Q1 | -1.4 Million USD | 60.0% |
| 1998 Q4 | -3.1 Million USD | -106.67% |
| 1997 Q4 | -3.5 Million USD | -94.44% |
| 1997 Q3 | -1.8 Million USD | -700.0% |
| 1997 Q2 | 300 Thousand USD | 120.0% |
| 1997 Q1 | -1.5 Million USD | 48.28% |
| 1997 FY | -6.4 Million USD | 11.11% |
| 1996 Q1 | -1.5 Million USD | 44.44% |
| 1996 Q2 | -1.2 Million USD | 20.0% |
| 1996 FY | -7.2 Million USD | 13.25% |
| 1996 Q4 | -2.9 Million USD | -70.59% |
| 1996 Q3 | -1.7 Million USD | -41.67% |
| 1995 FY | -8.3 Million USD | -36.07% |
| 1995 Q1 | -4 Million USD | -37.93% |
| 1995 Q4 | -2.7 Million USD | -42.11% |
| 1995 Q3 | -1.9 Million USD | 47.22% |
| 1995 Q2 | -3.6 Million USD | 10.0% |
| 1994 Q2 | -900 Thousand USD | -12.5% |
| 1994 Q3 | -1.7 Million USD | -88.89% |
| 1994 Q4 | -2.9 Million USD | -70.59% |
| 1994 FY | -6.1 Million USD | -662.5% |
| 1994 Q1 | -800 Thousand USD | -33.33% |
| 1993 Q4 | -600 Thousand USD | -700.0% |
| 1993 Q3 | 100 Thousand USD | 125.0% |
| 1993 Q2 | -400 Thousand USD | 0.0% |
| 1993 Q1 | -400 Thousand USD | 0.0% |
| 1993 FY | -800 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -183.881% |
| Arrayit Corporation | -3.62 Million USD | 2.67% |
| Atlantic International Corp. | -5.73 Million USD | 38.495% |
| Biocept, Inc. | -31.98 Million USD | 88.976% |
| Bioqual, Inc. | -19.63 Thousand USD | -17853.962% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -356.626% |
| DermTech, Inc. | -103.73 Million USD | 96.601% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.142% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 83.073% |
| iMD Companies, Inc. | -175.44 Thousand USD | -1909.621% |
| IDenta Corp. | -1499.00 USD | -235110.073% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 225.742% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 9212.946% |
| InVitro International | -25.33 Thousand USD | -13814.515% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 50.494% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -5967.248% |
| Medical Imaging Corp. | -819.48 Thousand USD | -330.248% |
| Optigenex Inc. | 1.39 Million USD | 353.502% |
| PharmChem, Inc. | 973.14 Thousand USD | 462.309% |
| Proteome Sciences plc | -1.62 Million USD | -117.508% |
| Response Genetics, Inc | -21.37 Million USD | 83.507% |
| Rennova Health, Inc. | -1.4 Million USD | -150.139% |
| RushNet, Inc. | -684.7 Thousand USD | -414.937% |
| ScreenPro Security Inc. | -2.59 Million USD | -36.004% |
| Stella Diagnostics Inc. | -11.42 Million USD | 69.145% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 54.487% |
| Todos Medical Ltd. | -9.74 Million USD | 63.831% |